Brief: Isofol Medical Plans Rights Issue Of About SEK 400 MLN

Isofol Medical AB (publ)

19/05/2021 06:40

May 19 (Reuters) - Isofol Medical AB  ISOFOL.ST :
    * SAID ON TUESDAY RESOLVED ON RIGHTS ISSUE OF UP TO 62.5 MLN
SHARES 
    * SUBSCRIPTION PRICE IS SEK 6.40 PER SHARE
    * IF RIGHTS ISSUE IS FULLY SUBSCRIBED, THE COMPANY WILL
RECEIVE
ABOUT SEK 400 MLN BEFORE TRANSACTION COSTS 
    * PROVIDED THE RIGHTS ISSUE IS OVERSUBSCRIBED, THE BOARD IS
AUTHORIZED TO CARRY OUT A DIRECTED SHARE ISSUE OF UP TO SEK 100
MILLION 
    * FOR EXISTING SHAREHOLDERS NOT PARTICIPATING IN THE RIGHTS
ISSUE,
A DILUTION EFFECT CORRESPONDING TO 42.9% OF THE TOTAL NUMBER OF
SHARES AND VOTES IN THE COMPANY FOLLOWING THE RIGHTS ISSUE WILL
ARISE
    * WILL USE ISSUE PROCEEDS FOR I) FUNDING THE ONGOING AGENT
STUDY
BEYOND TOP-LINE AND FINAL RESULTS AND ACTIVITIES FOR
FINALIZATION OF THE NDA APPLICATION, (II) FINALIZING THE
DEVELOPMENT AND VALIDATION OF CMC, III) GLOBAL PREPAREDNESS
ACTIVITIES

 Source text for Eikon:  urn:newsml:reuters.com:*:nWkr8Knkp7
 Further company coverage:  ISOFOL.ST 
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))